TRIFERIC AVNU Solution for injection Ref.[10336] Active ingredients:

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

Triferic AVNU (ferric pyrophosphate citrate), an iron replacement product, is a mixed-ligand iron complex in which iron (III) is bound to pyrophosphate and citrate. It has a molecular formula of Fe4(C6H4O7)3(H2P2O7)2(P2O7) and a relative molecular weight of approximately 1313 daltons.

Ferric pyrophosphate citrate has the following structure:

Triferic AVNU (ferric pyrophosphate citrate) injection is a clear, slightly yellow-green color sterile solution containing 6.75 mg of elemental iron (III) per 4.5 mL (1.5 mg iron (III) per mL) filled in a 5 mL low density polyethylene (LDPE) luer-lock ampule. Each Triferic AVNU ampule contains iron (0.14-0.17% w/w), and less than 0.1% w/w citrate, pyrophosphate, phosphate, sodium and sulfate. One Triferic AVNU ampule is administered directly into the pre-dialyzer infusion line, post-dialyzer infusion line, or to a separate connection to the venous blood line over 3 to 4 hours.

Dosage Forms and Strengths

Injection: 6.75 mg iron (III) per 4.5 mL solution (1.5 mg iron (III) per mL) in single-dose luer lock ampule.

How Supplied

Triferic AVNU injection is a clear to slightly yellow-green solution available in single-dose luer lock ampules in the following package sizes:

NDC CodePackage DescriptionAmount/Total Volume (per ampule)
NDC 57278-318-01 10 Luer-lock ampules per pouch 6.75 mg iron (III)/4.5 mL (1.5 mg iron (III) per mL)
NDC 57278-318-02 4 Pouches per Carton

Drugs

Drug Countries
TRIFERIC United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.